Hemanext is a medical technology company with headquarters and R&D Center of Excellence in Lexington MA, and manufacturing operations in Avon MA. Hemanext is committing its resources to the continuing effort of the transfusion medicine community to save lives and improve patient outcomes. Our distinctive focus is on innovations in systems enabling blood collection, processing, storage and transfusion that will promote dramatic improvements in transfusion therapies. For more information, visit www.hemanext.com.
Looking for a particular Hemanext employee's phone or email?
The Hemanext annual revenue was $15.8 million in 2026.
Andrew Dunham is the CEO of Hemanext.
36 people are employed at Hemanext.
Hemanext is based in Lexington, Massachusetts.
The NAICS codes for Hemanext are [541, 33, 339, 54171, 541714, 54, 5417].
The SIC codes for Hemanext are [86, 38, 382].